Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities.
Policy Notices
- Reminder: NIH Natural Disaster Policy Hurricane Isaias, Derecho
National Institutes of Health
- Notice of Correction to Eligibility in NIH Funding Opportunity Announcements
National Institutes of Health
General Notices
- Notice of Expiration of NOT-EB-20-006 "Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)"
National Institute of Biomedical Imaging and Bioengineering
- Findings of research misconduct
National Institutes of Health
- NCATS Announces Plans to Publish the ASPIRE 2020 Reduction-to-Practice Challenge Prize Competition
National Center for Advancing Translational Sciences
- Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
- Request for Information (RFI) on Encouraging AAALAC International-Accredited Institutions to Use Sections of the AAALAC Program Description in the OLAW Animal Welfare Assurance
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Change to RFA-AG-21-026 Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed)
National Institute on Aging
- Notice of Change to Research and Related Other Project Information (Pilot and Feasibility Program) Instructions for RFA-DK-20-002: NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Funding Opportunity Description of RFA-DK-20-011 "Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Funding Opportunity Description of RFA-DK-20-012 "Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Application Instructions for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of NIGMS Participation in NOT-ES-20-018 Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution
National Institute of General Medical Sciences
- Notice of Change: Emphasizing an Opportunity for New Institutional Applicants in Response to PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
National Human Genome Research Institute
- Notice of NHLBI Participation in PAR-19-051 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)"
National Heart, Lung, and Blood Institute
- Notice of Application Due Date Change for RFA-HL-20-021 "Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)"
National Heart, Lung, and Blood Institute
- Notice to Extend RFA-MH-19-135 - BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Notice to Extend RFA-MH-20-135 BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Notice of Change to Key Dates for RFA-NS-18-011 "Translational Neural Devices (UG3/UH3 Clinical Trial Required)"
National Institute of Neurological Disorders and Stroke
- Notice of Change to Key Dates for RFA-NS-18-012 "Translational Neural Devices (U44 Clinical Trial Required)"
National Institute of Neurological Disorders and Stroke
- Notice of Change to Key Dates for PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences
Notices of Special Interest
- Notice of Special Interest: Administrative Supplements for Connecting Pre-mortem Clinical Information with Post-Mortem Brain Analysis
National Institute of Neurological Disorders and Stroke
Funding Opportunities
- Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)
- New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional )
National Institute on Drug Abuse
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
National Cancer Institute
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
National Cancer Institute
- Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional)
National Cancer Institute
- NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)
- NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Glioblastoma Therapeutics Network (U19 Clinical Trial Required)
National Cancer Institute
- Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Center without Walls for Molecular Mechanisms of Neurodegeneration in Frontotemporal Degeneration (FTD) (U54 Clinical Trial not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu